Pyronaridine‐artesunate (PY‐AS) vs other antimalarials
Subsequent treatment(s), abnormal AST increase · adults and children with uncomplicated malaria
Pyronaridine‐artesunate (PY‐AS) showed no clear difference in subsequent treatment(s), abnormal AST increase compared with other antimalarials (low certainty).
1 finding from 1 review
- Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria 2022 · Cochrane Headline outcomes onlyRR 1.82 [0.74, 4.44]1 study · 1649 participantsLow